No items in cart
Existing Users please login here
Forgotten your password? Simply enter your email address above and hit "Login". Your password will be emailed to you shortly
E022 : Equest Pramox **** NEW 700KG SYRINGES ****
For oral administration. One 11.8g syringe contains sufficient gel to treat a 700kg horse at the recommended dose rate (0.4mg moxidectin per kg bodyweight and 2.5mg praziquantel per kg bodyweight).
Each graduation on the calibrated syringe delivers sufficient gel to treat 25kg bodyweight.
To avoid overdosing, care should be taken to accurately dose foals, especially low bodyweight foals or pony foals.
Mares & Foals
Now approved for mares in foal. Do not administer to young foals less than 6.5 months of age.
Horses cannot be slaughtered for human consumption within 64 days from the last treatment.
Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
In adults transient adverse reactions may occur at 3 times the recommended dose. The symptoms are depression, inappetence, ataxia, flaccid lower lip in the 8 to 24 hours following treatment. Symptomatic treatment is not generally necessary and recovery is generally complete within 24 to 72 hours.
The use of protective gloves is recommended
Wash hands or any exposed area after use.
Do not smoke, drink or eat while handling the product.
In the event of eye contact flush the eye with copious amounts of clean water and seek medical advice.
In case of accidental ingestion, seek medical help and show the doctor the package insert.
For animal treatment only.
Keep out of the reach and sight of children.
Read entire package insert before use.
Moxidectin is a second-generation macrocyclic lactone of the milbemycin family. Praziquantel is a parasiticide widely used in many species for the specific control of tapeworm. For the single dose treatment of mixed cestode and nematode or arthropod infections in horses and ponies; caused by moxidectin and praziquantel sensitive strains of:
The egg reappearance period of small redworm is 90 days.
The product is effective against (developing) intramucosal L4 stages of small redworm. At 8 weeks after treatment, early (hypobiotic/inhibited) EL3 stages of small redworm are eliminated.
The product is effective against benzimidazole resistant strains of cyathostomes.
|Option||Qty 1 - 5||Qty 6 - 14||Qty 15 - 25|
|Click to add||£ 23.50||£ 21.50||£ 21.00|